Wenxiang Wang

Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.

Shun Lü, Lin Wu, Wei Zhang et al. · Journal of Clinical Oncology · 2023 · 87 citations

Surgical Oncology, Interim Event-free Survival, Placebo Arm +15

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial

Dongsheng Yue, Wenxiang Wang, Hongxu Liu et al. · The Lancet Respiratory Medicine · 2024 · 76 citations

Interim Analysis, Surgical Oncology, Neoadjuvant Chemotherapy +12

Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III NEOTORCH study.

Shun Lü, Lin Wu, Wei Zhang et al. · Journal of Clinical Oncology · 2023 · 39 citations

Surgical Oncology, Interim Event-free Survival, Placebo Arm +14

Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study

Yu Zhao, Shan Xiong, Qin Ren et al. · The Lancet Oncology · 2024 · 38 citations

Spindle cell carcinoma of the esophagus

Baihua Zhang, Qin Xiao, Desong Yang et al. · Medicine · 2016 · 36 citations · Full text